ASDI Deploys ACD/1D NMR Assistant to Synthetic Chemists
News May 28, 2008
ASDI, Inc. recently implemented a suite of NMR software tools from ACD/Labs for use by their Synthetic Chemistry Team. Company believes that the new software is expected to dramatically increase the efficiency and cost-effectiveness of the group.
ASDI already employs a high-throughput structure verification routine in their analytical laboratory, analyzing over 1000 samples by NMR each week. The scheme uses Advanced Chemistry Development, Inc.'s, (ACD/Labs’) ACD/1D NMR Manager and ACD/HNMR Predictor to automatically evaluate the structure-to-spectrum match of 60–80% of those samples, making the high-volume analysis and interpretation possible.
The Synthetic Chemistry Team at ASDI determined that a similar tool would be useful in helping that group maximize its efficiency. However their needs were different than that of a high-throughput environment, and some of the software’s expert functionality was not needed. A better fit was found in ACD/1D NMR Assistant.
ACD/1D NMR Assistant was developed as a tool especially for chemists, and is tailored more closely to their workflow. It allows chemists to leave the instrument room and perform quick processing and reporting of NMR data from anywhere. The software’s true power lies in the ability to help evaluate the match between spectrum and structure, highlighting inconsistencies and focusing the chemist’s attention on the problematic areas.
ACD/1D NMR Assistant provides chemists with a software solution for viewing, processing, and reporting of spectra. Multiplet reports formatted for patents and publications can be produced with the click of a button.
The American Society of Human Genetics (ASHG), along with several co-signing organizations, issued a position statement today outlining whether, and to what extent, there is a responsibility to recontact genetic and genomic research participants when new findings emerge that suggest their genetic information should be interpreted differently, which would allow participants to benefit from current genomics advances.READ MORE